bosentan anhydrous has been researched along with Shock, Septic in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iskit, AB; Ozer, EK | 1 |
| Albertini, M; Borromeo, V; Ciminaghi, B; Clement, MG; Mazzola, S | 1 |
| Erni, D; Hiltebrand, LB; Krejci, V; Sigurdsson, GH | 1 |
| Guc, O; Iskit, AB | 1 |
| Mitaka, C | 1 |
| Guc, MO; Iskit, AB; Senel, I; Sokmensuer, C | 1 |
| Hemsén, A; Lundberg, JM; Modin, A; Rudehill, A; Wanecek, M; Weitzberg, E | 1 |
| Burman, HP; Cahill, PA; O'Donnell, CP; Robotham, JL; Yamamoto, S | 1 |
| Alving, K; Oldner, A; Rudehill, A; Sollevi, A; Wanecek, M; Weitzberg, E | 1 |
| Hemsén, A; Lundberg, JM; Rudehill, A; Wanecek, M; Weitzberg, E | 1 |
| McCartney, SA; Warner, TD | 1 |
| Alving, K; Goiny, M; Oldner, A; Rudehill, A; Sollevi, A; Wanecek, M; Weitzberg, E | 1 |
| Filep, JG | 1 |
| Guc, MO; Iskit, AB | 1 |
| Aspelin, T; Egeland, T; Höiby, EA; Lermark, G; Lyberg, T; Saetre, T; Svindland, A | 1 |
| Albertini, M; Ciminaghi, B; Clement, MG; Mazzola, S | 1 |
| Alving, K; Oldner, A; Rudehill, A; Wanecek, M; Weitzberg, E | 1 |
2 review(s) available for bosentan anhydrous and Shock, Septic
| Article | Year |
|---|---|
Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock.
Topics: Animals; Bacterial Translocation; Bosentan; Endothelin Receptor Antagonists; Endothelins; Guanidines; Humans; Multiple Organ Failure; Nitric Oxide; Nitric Oxide Synthase; Shock, Septic; Splanchnic Circulation; Sulfonamides | 2003 |
[Septic shock and endothelin].
Topics: Animals; Bosentan; Bronchoconstriction; Capillary Permeability; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Humans; Multiple Organ Failure; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Shock, Septic; Sulfonamides; Vasoconstriction | 2004 |
15 other study(ies) available for bosentan anhydrous and Shock, Septic
| Article | Year |
|---|---|
Effects of endothelin and nitric oxide on cardiac muscle functions in experimental septic shock model.
Topics: Animals; Bosentan; Carbachol; Cardiotonic Agents; Endothelin Receptor Antagonists; Endothelins; Isoproterenol; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Papillary Muscles; Rats, Wistar; Shock, Septic; Sulfonamides | 2016 |
Effects of endothelin-1 (ET-1) and thrombin antagonism on cardiovascular and respiratory dysfunctions during endotoxic shock in pig.
Topics: Animals; Antihypertensive Agents; Bosentan; Cardiovascular System; Endothelin-1; Female; Fibrinolytic Agents; Hemodynamics; Hirudins; Lipopolysaccharides; Lung; Male; Recombinant Proteins; Respiratory System; Shock, Septic; Sulfonamides; Swine; Thrombin; Time Factors | 2002 |
Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock.
Topics: Acid-Base Equilibrium; Analysis of Variance; Animals; Antihypertensive Agents; Bosentan; Endothelins; Gastric Mucosa; Hemodynamics; Microcirculation; Shock, Septic; Splanchnic Circulation; Statistics, Nonparametric; Sulfonamides; Swine | 2003 |
Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock.
Topics: Animals; Antihypertensive Agents; Bosentan; Cecum; Disease Models, Animal; Endothelin Receptor Antagonists; Kidney; Ligation; Liver; Mice; Shock, Septic; Sodium Chloride; Spleen; Sulfonamides; Survival Rate; Time Factors; Wounds and Injuries | 2004 |
Bosentan-improved cardiopulmonary vascular performance and increased plasma levels of endothelin-1 in porcine endotoxin shock.
Topics: Animals; Blood Pressure; Bosentan; Dose-Response Relationship, Drug; Endothelin-1; Female; Heart Rate; Lipopolysaccharides; Male; Pulmonary Circulation; Shock, Septic; Sulfonamides; Swine; Time Factors; Vascular Resistance | 1996 |
Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock.
Topics: Analysis of Variance; Animals; Bosentan; Cyclooxygenase Inhibitors; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Endotoxemia; Hemodynamics; Hypertension, Portal; Hypertension, Pulmonary; Indomethacin; Liver Circulation; Portal System; Pulmonary Artery; Pulmonary Circulation; Regional Blood Flow; Shock, Septic; Sulfonamides; Swine; Thromboxane B2; Vascular Resistance | 1997 |
Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan.
Topics: Acid-Base Imbalance; Animals; Bosentan; Cardiovascular Diseases; Endothelin Receptor Antagonists; Endothelin-1; Female; Hemoglobins; Hypertension, Pulmonary; Lactic Acid; Male; Oxygen Consumption; Shock, Septic; Sulfonamides; Swine; Treatment Outcome; Tumor Necrosis Factor-alpha | 1997 |
The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
Topics: Animals; Bosentan; Cyclooxygenase Inhibitors; Diclofenac; Drug Therapy, Combination; Endothelin Receptor Antagonists; Escherichia coli Infections; Hemodynamics; Hypertension, Pulmonary; Renal Circulation; Shock, Septic; Sulfonamides; Swine | 1997 |
Shock news for the gut.
Topics: Antihypertensive Agents; Bosentan; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Endotoxins; Humans; Intestinal Mucosa; Intestines; Ischemia; Shock, Septic; Sulfonamides; Time Factors | 1998 |
The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock.
Topics: Acidosis; Animals; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Escherichia coli; Intestinal Mucosa; Intestines; Ischemia; Lipopolysaccharides; Oxygen; Shock, Septic; Splanchnic Circulation; Sulfonamides; Swine | 1998 |
Role for endogenous endothelin in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats.
Topics: Animals; Azepines; Bacterial Toxins; Blood Pressure; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Enterotoxins; Erythrocyte Volume; Escherichia coli Proteins; Indoles; Lipopolysaccharides; Male; Plasma Volume; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Regional Blood Flow; Serum Albumin; Serum Albumin, Radio-Iodinated; Shock, Septic; Sulfonamides | 2000 |
The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock.
Topics: Animals; Antihypertensive Agents; Bosentan; Canavanine; Disease Models, Animal; Endothelin Receptor Antagonists; Endotoxins; Enzyme Inhibitors; Guanidines; Lipopolysaccharides; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Shock, Septic; Sulfonamides; Survival Rate | 2001 |
Aminoethyl-isothiourea inhibits the increase in plasma endothelin-1 caused by serogroup A streptococci and prolongs survival in rat peritoneal sepsis.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Shock, Septic; Streptococcal Infections; Streptococcus pyogenes; Sulfonamides; Survival Rate; Thiourea; Time Factors | 2001 |
Improvement of respiratory function by bosentan during endotoxic shock in the pig.
Topics: Animals; Antihypertensive Agents; Bosentan; Enzyme Inhibitors; Female; Hypertension, Pulmonary; Lipopolysaccharides; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pulmonary Edema; Respiration; Shock, Septic; Sulfonamides; Swine; Time Factors | 2001 |
Effects of the endothelin receptor antagonist bosentan on cardiac performance during porcine endotoxin shock.
Topics: Animals; Bosentan; Cardiac Output; Coronary Circulation; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Pulmonary Circulation; Shock, Septic; Stroke Volume; Sulfonamides; Swine; Ventricular Function, Left | 2001 |